Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series
Xavier Solanich, Gardenia Vargas-Parra, Caspar I. van der Made, Annet Simons, Janneke Schuurs-Hoeijmakers, Arnau Antolí, Jesús del Valle, Gemma Rocamora-Blanch, Fernando Setién, Manel Esteller, Antoni Riera-Mestre, Joan Sabater-Riera, Gabriel Capellá, Frank L. van de Veerdonk, Ben van der Hoven, Xavier Corbella, Alexander Hoischen, Conxi Lázaro
doi: https://doi.org/10.1101/2021.03.14.21252289
Xavier Solanich
1Department of Medicina Interna. Hospital Universitari de Bellvitge - IDIBELL. L’Hospitalet de Llobregat, Barcelona, Spain
MDGardenia Vargas-Parra
2Hereditary Cancer Program, Catalan Institute of Oncology, Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
MD, PhDCaspar I. van der Made
4Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
5Radboud University Medical Center Center for Infectious Diseases (RCI), Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
6Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
7Radboud Expertise Center for Immunodeficiency and Autoinflammation and Radboud Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, the Netherlands
Annet Simons
4Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
Janneke Schuurs-Hoeijmakers
4Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
Arnau Antolí
1Department of Medicina Interna. Hospital Universitari de Bellvitge - IDIBELL. L’Hospitalet de Llobregat, Barcelona, Spain
MDJesús del Valle
2Hereditary Cancer Program, Catalan Institute of Oncology, Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
PhDGemma Rocamora-Blanch
1Department of Medicina Interna. Hospital Universitari de Bellvitge - IDIBELL. L’Hospitalet de Llobregat, Barcelona, Spain
MDFernando Setién
8Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain
PhDManel Esteller
3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
8Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain
9Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
10Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain
MD, PhDAntoni Riera-Mestre
1Department of Medicina Interna. Hospital Universitari de Bellvitge - IDIBELL. L’Hospitalet de Llobregat, Barcelona, Spain
11Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain
MD, PhDJoan Sabater-Riera
12Department of intensive Care. Hospital Universitari de Bellvitge - IDIBELL. L’Hospitalet de Llobregat, Barcelona, Spain
MD, PhDGabriel Capellá
2Hereditary Cancer Program, Catalan Institute of Oncology, Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
MD, PhDFrank L. van de Veerdonk
5Radboud University Medical Center Center for Infectious Diseases (RCI), Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
6Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
7Radboud Expertise Center for Immunodeficiency and Autoinflammation and Radboud Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, the Netherlands
Ben van der Hoven
13Department of Intensive Care, Erasmus MC, Rotterdam, the Netherlands
Xavier Corbella
1Department of Medicina Interna. Hospital Universitari de Bellvitge - IDIBELL. L’Hospitalet de Llobregat, Barcelona, Spain
14School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain
MD, PhDAlexander Hoischen
4Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
5Radboud University Medical Center Center for Infectious Diseases (RCI), Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
6Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
7Radboud Expertise Center for Immunodeficiency and Autoinflammation and Radboud Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, the Netherlands
Conxi Lázaro
2Hereditary Cancer Program, Catalan Institute of Oncology, Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
PhDData Availability
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Posted March 25, 2021.
Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series
Xavier Solanich, Gardenia Vargas-Parra, Caspar I. van der Made, Annet Simons, Janneke Schuurs-Hoeijmakers, Arnau Antolí, Jesús del Valle, Gemma Rocamora-Blanch, Fernando Setién, Manel Esteller, Antoni Riera-Mestre, Joan Sabater-Riera, Gabriel Capellá, Frank L. van de Veerdonk, Ben van der Hoven, Xavier Corbella, Alexander Hoischen, Conxi Lázaro
medRxiv 2021.03.14.21252289; doi: https://doi.org/10.1101/2021.03.14.21252289
Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series
Xavier Solanich, Gardenia Vargas-Parra, Caspar I. van der Made, Annet Simons, Janneke Schuurs-Hoeijmakers, Arnau Antolí, Jesús del Valle, Gemma Rocamora-Blanch, Fernando Setién, Manel Esteller, Antoni Riera-Mestre, Joan Sabater-Riera, Gabriel Capellá, Frank L. van de Veerdonk, Ben van der Hoven, Xavier Corbella, Alexander Hoischen, Conxi Lázaro
medRxiv 2021.03.14.21252289; doi: https://doi.org/10.1101/2021.03.14.21252289
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (3002)
- Dermatology (256)
- Emergency Medicine (449)
- Epidemiology (12900)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4698)
- Geriatric Medicine (432)
- Health Economics (742)
- Health Informatics (2986)
- Health Policy (1081)
- Hematology (399)
- HIV/AIDS (942)
- Medical Education (439)
- Medical Ethics (116)
- Nephrology (481)
- Neurology (4486)
- Nursing (239)
- Nutrition (657)
- Oncology (2329)
- Ophthalmology (659)
- Orthopedics (262)
- Otolaryngology (330)
- Pain Medicine (290)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1218)
- Primary Care Research (509)
- Public and Global Health (7073)
- Radiology and Imaging (1570)
- Respiratory Medicine (933)
- Rheumatology (454)
- Sports Medicine (390)
- Surgery (497)
- Toxicology (62)
- Transplantation (214)
- Urology (187)